Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Thromb Res ; 130(4): 646-8, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-22178578

RESUMEN

INTRODUCTION: The thrombin mutant W215A/E217A (WE thrombin) has greatly reduced procoagulant activity, but it activates protein C in the presence of thrombomodulin and inhibits binding of platelet glycoprotein Ib to von Willebrand factor and collagen under flow conditions. Both thrombomodulin-dependent protein C activation and inhibition of platelet adhesion could contribute to the antithrombotic activity of WE thrombin. MATERIALS AND METHODS: To assess the role of thrombomodulin, we administered WE thrombin to thrombomodulin-deficient (TM(Pro/Pro)) mice and measured the time to occlusive thrombus formation in the carotid artery after photochemical injury of the endothelium. RESULTS AND CONCLUSIONS: Doses of WE thrombin ≥10µg/kg prolonged the thrombosis time of wild-type mice (>1.6-fold), while doses ≥100µg/kg only slightly prolonged the thrombosis time of TM(Pro/Pro) mice. We conclude that thrombomodulin plays a predominate role in mediating the antithrombotic effect of WE thrombin in the arterial circulation of mice after endothelial injury. Thrombomodulin-independent effects may occur only when high doses of WE thrombin are administered.


Asunto(s)
Arterias Carótidas/efectos de los fármacos , Trombosis de las Arterias Carótidas/tratamiento farmacológico , Trombosis de las Arterias Carótidas/patología , Fibrinolíticos/uso terapéutico , Trombina/uso terapéutico , Trombomodulina/metabolismo , Animales , Arterias Carótidas/metabolismo , Arterias Carótidas/patología , Trombosis de las Arterias Carótidas/metabolismo , Fibrinolíticos/metabolismo , Eliminación de Gen , Ratones , Ratones Endogámicos C57BL , Mutación Puntual , Ingeniería de Proteínas , Trombina/genética , Trombomodulina/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA